References
Original article
Schuster, S. J. et al. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. https://doi.org/10.1016/S1470-2045(21)00375-2 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. Long-term data on tisagenlecleucel. Nat Rev Clin Oncol 18, 676 (2021). https://doi.org/10.1038/s41571-021-00567-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00567-0
- Springer Nature Limited